Actuate Therapeutics Inc: Navigating Financial Volatility in the Biopharmaceutical Sector
Actuate Therapeutics Inc’s stock has experienced significant volatility, with a market capitalization of $202.15 million, as the company navigates the challenges of developing novel cancer therapies in the highly competitive biopharmaceutical sector.
3 minutes to read